Literature DB >> 6847791

Total cholesterol and lipoproteins in school children: prediction of coronary heart disease in adult relatives.

P P Moll, C F Sing, W H Weidman, H Gordon, R D Ellefson, P A Hodgson, B A Kottke.   

Abstract

The distribution of risk factors and the prevalence of coronary heart disease (CHD) were studied in 850 first- and second-degree relatives of 98 healthy index cases selected from 3666 school children surveyed for lipid levels in Rochester, Minnesota. Three groups of families were based on an index child's total plasma cholesterol level: 18 families with a child in less than the fifth percentile (low-cholesterol group), 47 with a child in the fifth to ninety-fifth percentiles (middle-cholesterol group) and 33 with a child in greater than the ninety-fifth percentile (high-cholesterol group). The children's cholesterol levels clustered with those of their relatives; mortality due to CHD before age 65 was increased by 2.5 times in grandfathers of index cases in the high-cholesterol group compared with those of the middle-cholesterol group (p less than 0.016). The prevalence of CHD in all the grandfathers was associated with an index child's total cholesterol, more strongly associated with an index child's low-density lipoprotein cholesterol level and most strongly associated with an index child's high-density lipoprotein cholesterol level as a fraction of total cholesterol. This study establishes that childhood lipid and lipoprotein levels from a single cross-sectional survey identify families at elevated risk for CHD.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6847791     DOI: 10.1161/01.cir.67.1.127

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Detection of genetic heterogeneity among pedigrees through complex segregation analysis: an application to hypercholesterolemia.

Authors:  P P Moll; T D Berry; W H Weidman; R Ellefson; H Gordon; B A Kottke
Journal:  Am J Hum Genet       Date:  1984-01       Impact factor: 11.025

2.  Lipid profile in the progeny of parents with ischemic heart disease.

Authors:  I B Parmar; P H Singh; V Singh
Journal:  Indian J Pediatr       Date:  2001-07       Impact factor: 1.967

3.  Sibling history of myocardial infarction or stroke and risk of cardiovascular disease in the elderly: the Cardiovascular Health Study.

Authors:  N David Yanez; Gregory L Burke; Teri Manolio; Julius M Gardin; Joseph Polak
Journal:  Ann Epidemiol       Date:  2009-12       Impact factor: 3.797

4.  Cholesterol screening and family history of vascular disease.

Authors:  E D Primrose; J M Savage; C A Boreham; G W Cran; J J Strain
Journal:  Arch Dis Child       Date:  1994-09       Impact factor: 3.791

5.  Regional association-based fine-mapping for sodium-lithium countertransport on chromosome 10.

Authors:  Alanna C Morrison; Eric Boerwinkle; Stephen T Turner; Robert E Ferrell
Journal:  Am J Hypertens       Date:  2008-01       Impact factor: 2.689

6.  Association of SLC34A2 variation and sodium-lithium countertransport activity in humans and baboons.

Authors:  Xiaojing Zheng; Candace M Kammerer; Laura A Cox; Alanna Morrison; Stephen T Turner; Robert E Ferrell
Journal:  Am J Hypertens       Date:  2009-01-01       Impact factor: 2.689

Review 7.  [Coronary heart disease: epidemiologic-genetic aspects].

Authors:  F H Epstein
Journal:  Soz Praventivmed       Date:  1985

8.  Variation in Child Serum Cholesterol and Prevalence of Familiar Hypercholesterolemia: The Health Oriented Pedagogical Project (HOPP).

Authors:  Ester Fabiani; Martin Frank Strand; Morten Lindberg; Nandu Goswami; Per Morten Fredriksen
Journal:  Glob Pediatr Health       Date:  2022-03-23

9.  Universal screening for cardiovascular disease risk factors in adolescents to identify high-risk families: a population-based cross-sectional study.

Authors:  Michael Khoury; Cedric Manlhiot; Don Gibson; Nita Chahal; Karen Stearne; Stafford Dobbin; Brian W McCrindle
Journal:  BMC Pediatr       Date:  2016-01-21       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.